title: Effects of cyclophosphamide in newly hatched chickens after inoculation with avian nephritis virus.
abstract: Effects of immunosuppression were compared in newly hatched chickens given cyclophosphamide (CY) after inoculation with avian nephritis virus (ANV). All CY-treated infected chickens died within 13 days after inoculation of the virus and had heavy urate deposits throughout the body. However, non-CY-treated infected, CY-treated noninfected, and non-CY-treated noninfected control chickens survived through the observation period. In a chronologic study, the value of serum uric acid in CY-treated infected chickens was more than 3 times higher than that in non-CY-treated infected chickens, and more than 9 times higher than in noninfected chickens. Serum uric acid values were coincident with the positive degree of ANV antigen in the tubular epithelial cells in the kidneys and with the severity of renal degeneration. Serologic and immunohistologic examinations did not reveal detectable antibody and IgG- and IgM-containing cells in the spleen and kidneys of CY-treated infected chickens. However, non-CY-treated infected chickens had an increased number of IgM- and IgG-containing cells and antibody against ANV on postinoculation day 6. These findings demonstrated that CY treatment enhanced the susceptibility of chickens to ANV infection.
authors.affiliation: Poultry Disease Laboratory, National Institute of Animal Health, Gifu, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Narita
authors.forename: H
authors.initials: H
authors.lastname: Kawamura
authors.forename: K
authors.initials: K
authors.lastname: Furuta
authors.forename: J
authors.initials: J
authors.lastname: Shirai
authors.forename: K
authors.initials: K
authors.lastname: Nakamura
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D000921:Antibody-Producing Cells / Q000187:drug effects*; D000956:Antigens, Viral / Q000276:immunology; D002645:Chickens / Q000097:blood / Q000276:immunology* / Q000382:microbiology; D003520:Cyclophosphamide / Q000494:pharmacology*; D007165:Immunosuppression Therapy / Q000009:adverse effects / Q000662:veterinary*; D007243:Infectious bursal disease virus / Q000276:immunology; D011201:Poultry Diseases / Q000097:blood / Q000209:etiology* / Q000401:mortality / Q000473:pathology; D012192:Retroviridae Infections / Q000097:blood / Q000401:mortality / Q000473:pathology / Q000662:veterinary*; D013047:Specific Pathogen-Free Organisms; D014527:Uric Acid / Q000097:blood
chemical_list: D000956:Antigens, Viral; D014527:Uric Acid; D003520:Cyclophosphamide